SecBot SecBot
SECBOTREPLAY Home › Report › REGN

REGN · Seven Regeneron insiders sold a total of $9.56M in open-market sales…

REGENERON PHARMACEUTICALS, INC. · CLUSTER filed Nov 5, 2026 at 16:05 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Nov 5, 2026 at 16:05 ET

Seven Regeneron insiders sold a total of $9.56M in open-market sales over the week following a strong Q3 earnings beat (revenue +36% YoY, EPS +35% YoY). The sales include two C-suite executives (EVP General Counsel and EVP Commercial) and five directors; two of the sales were under 10b5-1 plans. The total represents ~0.01% of market cap, well below the 0.1% threshold for materiality, making this a routine cluster likely driven by post-earnings window openings and personal portfolio management.

  • Seven insiders sold $9.56M in open-market sales (code S) over a 7-day window ending Nov 4, 2026
  • Sales follow Q3 2026 earnings on Oct 30: revenue $5.116B (+36% YoY), GAAP EPS $18.45 (+35% YoY), both above consensus
  • Total sales are ~0.01% of $96.3B market cap, far below the 0.1% materiality threshold
  • Two sales (Brown, McCourt, Guarini) were under 10b5-1 plans; four were not; one (Pitofsky) is detailed separately with derivative exercises

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access